NCT06609720

Brief Summary

Randomized clinical and radiographic trial

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2021

Completed
2.8 years until next milestone

First Submitted

Initial submission to the registry

December 5, 2023

Completed
7 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 12, 2023

Completed
18 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2023

Completed
9 months until next milestone

First Posted

Study publicly available on registry

September 24, 2024

Completed
Last Updated

September 24, 2024

Status Verified

February 1, 2021

Enrollment Period

2.8 years

First QC Date

December 5, 2023

Last Update Submit

September 23, 2024

Conditions

Keywords

dentin graft, tooth graft

Outcome Measures

Primary Outcomes (3)

  • Probing pocket depth

    According to Ramfjord, clinical parameter measured by UNC periodontal probe from a fixed point to the deepest probing depth. Using stent to standardize the measurements.

    Measured at baseline, 6 months and 12 months

  • Clinical attachment level

    According to Ramfjord, clinical parameter measured by a Naber\'s probe. Using stent to standard measurements.

    Measured at baseline, 6 months and 12 months

  • Bleeding on probing

    According to Ramfjord, the bleeding at each site observed after probing and recorded positive if bleeding was observed within 30 seconds, if not was recorded as negative.

    Measured at baseline, 6 months and 12 months

Secondary Outcomes (1)

  • Radiographic outcome

    measured at baseline and 1 year follow up

Study Arms (4)

Group 1 subgroup A

EXPERIMENTAL

Grade II furcation involvement treated with autogenous dentin graft

Procedure: (guided tissue regeneration)

Group 1 Subgroup B

EXPERIMENTAL

Grade II furcation involvement treated with demineralized freeze-dried bone allograft

Procedure: (guided tissue regeneration)

Group II subgroup A

EXPERIMENTAL

Grade III furcation involvement treated with Autogenous dentin graft

Procedure: (guided tissue regeneration)

Group II subgroup B

EXPERIMENTAL

Grade III furcation involvement treated with demineralized freeze-dried bone allograft

Procedure: (guided tissue regeneration)

Interventions

Randomized clinical and radiographic trial

Group 1 Subgroup BGroup 1 subgroup AGroup II subgroup AGroup II subgroup B

Eligibility Criteria

Age35 Years - 55 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Presence of class II and/or ΙΙΙ furcation defects in mandibular first or second molars according to criteria outlined by Hamp et. al. 1975.
  • Horizontal probing depth ≥3 mm using Naber's probe.
  • Clinical attachment level ≥3 mm measured from cemento-enamel junction (CEJ) till the deepest probing depth.
  • Evidence of radiolucency in the furcation area on panoramic radiograph.
  • Patients who will be assigned for groups (I and II) should present with teeth required for extraction due to advanced periodontal bone loss or other indications such as hopeless wisdom teeth or orthodontic indications or unrestorable fractured teeth as a source for autogenous dentin graft (ADG).

You may not qualify if:

  • Medically compromised patients and systemic conditions precluding periodontal surgery.
  • Mandibular first or second molars with root caries or endodontic treatment.
  • Smokers, diabetics, pregnant or lactating women.
  • History of chemotherapy, radiotherapy in head and/or neck region.
  • Bisphosphonate therapy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of dentistry

Tanta, Egypt

Location

MeSH Terms

Interventions

Guided Tissue Regeneration

Intervention Hierarchy (Ancestors)

Plastic Surgery ProceduresSurgical Procedures, Operative

Study Officials

  • Banan L Amer, Master

    Tanta University

    PRINCIPAL INVESTIGATOR
  • Samia A Darwish, Professor

    Tanta University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: 2 groups with 2 subgroups, each subgroup receive either ADG or DFDBA
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant lecturer at periodontology department, Principal Investigator, MSC

Study Record Dates

First Submitted

December 5, 2023

First Posted

September 24, 2024

Study Start

March 1, 2021

Primary Completion

December 12, 2023

Study Completion

December 30, 2023

Last Updated

September 24, 2024

Record last verified: 2021-02

Data Sharing

IPD Sharing
Will not share

Locations